Health TrialsbyHealthPanel

Opt-IVF for Personalized Medicine for Normal Responders

ConditionIvf
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age20-50
SponsorUrmila DIwekar

About this trial

A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

PCOS and Poor Responders

Trial design

Design model

Parallel

Treatments tested in this trial

  • Opt-IVF

    Device

    Opt-IVF predicted dosage for IVF

  • control

    Other intervention

    Doctor prescribed dosage

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Opt-IVFExperimental treatment 1 intervention
Group B: ControlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Total Gonadotropin dosage

Total Dosage

Time frame
11 days

Secondary outcomes

1

M2 Oocytes

M2 Oocytes

Time frame
13 days
2

Total Embryos

Number of Embryos

Time frame
15 days
3

Grade A Blastocysts

No. of Grade A blastocysts

Time frame
20 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Urmila DIwekar

Lead sponsor

Stochastic Research Technologies LLC

Sponsor institution

Source ClinicalTrials.gov
Apply now